REVMAB BIOSCIENCES Trademark

Trademark Overview

On Thursday, October 3, 2013, a trademark application was filed for REVMAB BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the REVMAB BIOSCIENCES trademark a serial number of 86975709. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, May 15, 2024. This trademark is owned by RevMAb Biosciences USA, Inc.. The REVMAB BIOSCIENCES trademark is filed in the Chemical Products category with the following description:

Biochemicals, namely, monoclonal antibodies for research or in vitro research use
revmab biosciences

General Information

Serial Number86975709
Word MarkREVMAB BIOSCIENCES
Filing DateThursday, October 3, 2013
Status800 - REGISTERED AND RENEWED
Status DateWednesday, May 15, 2024
Registration Number4664916
Registration DateTuesday, December 30, 2014
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 1, 2014

Trademark Statements

Description of MarkThe mark consists of the wording "RevMAb Biosciences" with the letters "R", "MA", and "B" capitalized. The wording "RevMAb" appears above the word "Biosciences", with the letter "B" placed under the letter "e" in "RevMAb". The letter "v" in "RevMAb" and the first letter "i" in "Biosciences" are formed by a stylized molecular structure that connects the two letters, where each side of the "v" is formed by a parallelogram and the "i" is formed by a six-sided chevron shape coming to a point at the bottom.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesBiochemicals, namely, monoclonal antibodies for research or in vitro research use

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, October 10, 2013
Primary Code001
First Use Anywhere DateSaturday, March 1, 2014
First Use In Commerce DateSaturday, March 1, 2014

Trademark Owner History

Party NameRevMAb Biosciences USA, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBurlingame, CA 94010
Party NameRevMAb Biosciences USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameRevMAb Biosciences USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Friday, January 17, 2014ASSIGNED TO EXAMINER
Monday, October 7, 2013NEW APPLICATION ENTERED
Thursday, October 10, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 11, 2013NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, January 22, 2014NON-FINAL ACTION WRITTEN
Wednesday, January 22, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 22, 2014NON-FINAL ACTION E-MAILED
Friday, January 31, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 31, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, February 1, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 4, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 24, 2014ASSIGNED TO LIE
Wednesday, February 26, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 27, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 12, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 1, 2014PUBLISHED FOR OPPOSITION
Tuesday, April 1, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, October 9, 2014TEAS STATEMENT OF USE RECEIVED
Thursday, October 9, 2014TEAS REQUEST TO DIVIDE RECEIVED
Thursday, October 9, 2014DIVISIONAL REQUEST RECEIVED
Thursday, October 9, 2014USE AMENDMENT FILED
Thursday, November 6, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 7, 2014DIVISIONAL PROCESSING COMPLETE
Tuesday, December 30, 2014REGISTERED-PRINCIPAL REGISTER
Friday, November 7, 2014STATEMENT OF USE PROCESSING COMPLETE
Saturday, November 8, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, November 24, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, November 25, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, July 16, 2020TEAS SECTION 8 & 15 RECEIVED
Wednesday, September 23, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, December 30, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, September 21, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, December 30, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, January 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 24, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, January 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 3, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, January 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 29, 2024TEAS SECTION 8 & 9 RECEIVED
Wednesday, May 15, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, May 15, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 15, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, May 15, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Related Keywords

biosciences revmab research vitro antibodies monoclonal namely biochemicals